Pharmacy drug shortage response: a technician workflow

A local stockout is not automatically a nationwide drug shortage. Confirm the exact product and strength, check inventory and supplier availability, consult FDA’s current shortage information when appropriate, and route therapeutic alternatives to the pharmacist and prescriber rather than substituting on your own.

Stockout or shortage?

A product missing from one shelf can reflect a delivery delay, a local demand spike, a wholesaler allocation, or a national shortage. FDA’s public drug shortage database describes shortages known to the agency and is updated with product and status information. Begin with the exact drug, strength, dosage form, package, and manufacturer or NDC details; “the medication is unavailable” is too broad to support a safe search. Check the pharmacy’s on-hand stock, pending orders, approved alternate suppliers, and expected delivery time under local policy. Never promise a date based only on a wholesaler estimate.

Confirm the product precisely

Search by generic name or active ingredient in FDA’s shortage resources, then compare the listed presentation with the prescription. One strength or dosage form may be scarce while another remains available; a branded product and a generic product can have different supply status. An NDC or manufacturer match helps avoid treating a different formulation as interchangeable. Check whether the item is discontinued, recalled, temporarily unavailable, or part of an FDA-listed shortage. These statuses are not synonyms, and each has a different operational response.

What technicians can do

A technician can gather accurate facts: exact product requested, quantity needed, available stock, supplier response, patient timing, and any directly related alternatives already approved by pharmacy policy. The technician can communicate a stock delay using the pharmacy’s approved language and route clinical questions to the pharmacist. The technician should not select a therapeutic substitute, change strength or dosage form, extend beyond a prescribed course, or recommend a treatment switch. Those decisions require the pharmacist and often the prescriber. State law may define the technician’s role more narrowly.

Escalate before the patient runs out

If the patient says the medication is time-sensitive or they may miss a dose, alert the pharmacist promptly. Do not wait until an order’s expected arrival date passes. The pharmacist may evaluate whether another manufacturer’s equivalent product, another strength, an alternate therapy, a partial fill, or a new prescription is appropriate and lawful. The pharmacy should document the contact and outcome. If the prescription is for a high-risk medication, a patient with limited supply, or a product with special handling requirements, use the escalation pathway rather than leaving a voicemail in a routine queue.

Avoid unsafe workarounds

A shortage does not make a different drug automatically suitable. Verify dosage form, route, concentration, release mechanism, device, and patient-specific factors. Do not split, crush, dilute, compound, or repackage unless the pharmacist confirms that the action is clinically and legally appropriate and the product supports it. Do not use a product past its expiration date or an extended-use date unless the FDA has specifically identified that lot and the pharmacy’s process confirms it. FDA publishes certain extended-use dates to help mitigate shortages; these are not blanket extensions for every lot.

Communicate with the patient

Be concise and factual: explain which product is unavailable, what the supplier has told the pharmacy, whether the pharmacist is checking an option, and when the patient should expect an update. Do not speculate about when a national shortage will resolve. If no exact restock date is known, say so. Keep patient information private when calling another pharmacy or prescriber. When a patient reports a broader access problem, the pharmacist or organization may consider reporting new shortage information through FDA’s public portal after checking the database.

Close the loop

Track backorders and allocated quantities using the pharmacy’s inventory process. When stock arrives, match the shipment to the order and verify manufacturer, strength, dosage form, lot, expiration, and storage conditions. Remove obsolete backorder notes and update staff who are handling affected prescriptions. If the shortage is resolved, that does not mean every supplier immediately has stock. Use current supplier information and do not keep telling patients the product is unavailable based on an old note.

Exam and scope reminder

For the PTCE, distinguish a local stock problem from a listed shortage, identify exact product details, use FDA’s database as an information source, and escalate substitutions to the pharmacist. FDA does not choose a patient’s alternative therapy. The pharmacy’s safe response combines inventory facts, timely communication, and authorized clinical decision-making.

For each affected product, a log can record the generic name, strength, dosage form, package, NDC or manufacturer when relevant, date checked, on-hand quantity, supplier response, expected delivery if confirmed, and the staff member who checked. Separate confirmed facts from estimates. This helps the next technician avoid repeating a search and lets the pharmacist see which prescriptions face the most urgent interruption. Do not record unnecessary patient details in a general inventory log; keep clinical case information in the appropriate protected record.

Product-specific extended use dates

FDA may publish lot-specific expiration extensions for some products during a shortage. The extension applies only to listed lots and conditions, such as the exact product, strength, lot number, and storage history. Compare the physical package with the FDA notice; a matching drug name alone is insufficient. If any identifier does not match, do not treat the extension as applicable. Route the package and notice to the pharmacist or inventory lead for confirmation and documentation. An extension is distinct from a pharmacy-assigned beyond-use date for a compounded preparation.

Tell the difference between an alternative and a substitution

A wholesaler may offer another manufacturer of the same strength and dosage form, but even a product that appears similar needs the pharmacy’s product-selection and payer checks. A different salt, release form, concentration, device, or package may not be equivalent. Therapeutic alternatives are a clinical decision. The technician’s contribution is to supply exact inventory facts and communicate the delay so the pharmacist can make a timely plan.

Study summary

• Confirm the exact product, instructions, units, and applicable rules before acting.
• Use the written procedure and escalate unclear, unusual, or safety-sensitive cases to the pharmacist.